Sunday, September 08, 2024 2:27:02 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent YMAB News
- Y-mAbs to Participate at Citi’s 2024 Global Healthcare Conference • GlobeNewswire Inc. • 11/27/2024 12:35:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 09:32:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2024 12:18:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2024 11:55:20 AM
- Y-mAbs Reports Third Quarter 2024 Financial Results and Recent Corporate Developments • GlobeNewswire Inc. • 11/08/2024 11:35:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2024 01:51:28 PM
- Y-mAbs and Nobelpharma Announce Exclusive License and Distribution Agreement for DANYELZA® (naxitamab-gqgk) in Japan • GlobeNewswire Inc. • 11/04/2024 12:35:00 PM
- Y-mAbs Announces Third Quarter 2024 Conference Call and Webcast • GlobeNewswire Inc. • 10/25/2024 11:05:00 AM
- Y-mAbs to Participate in Upcoming Investor Conferences in October • GlobeNewswire Inc. • 10/01/2024 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 08:16:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/20/2024 08:15:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2024 12:05:37 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 09:24:01 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/13/2024 08:19:43 PM
- Y-mAbs Presents Neuroblastoma Research on Naxitamab and SADA PRIT Technology Platform at AACR Special Conference on Advances in Pediatric Cancer Research • GlobeNewswire Inc. • 09/06/2024 11:30:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/03/2024 09:00:28 PM
- Y-mAbs to Participate in Upcoming Investor Conferences in September • GlobeNewswire Inc. • 09/03/2024 12:32:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/30/2024 08:15:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/28/2024 09:12:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/27/2024 09:05:52 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/26/2024 08:12:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 11:06:29 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 10:50:43 AM
- Y-mAbs Reports Second Quarter 2024 Financial Results and Recent Corporate Developments • GlobeNewswire Inc. • 08/12/2024 10:30:00 AM
- Y-mAbs to Participate in Upcoming Investor Conferences in August • GlobeNewswire Inc. • 08/07/2024 11:05:00 AM
Avant Technologies' Partner, Ainnova, Signs Pilot Program with Roche to Combat Diabetic Retinopathy • AVAI • Dec 4, 2024 8:00 AM
North Bay Resources Commences Fran Gold Winter Ore Shipment to Bishop Gold Mill, California • NBRI • Dec 2, 2024 9:07 AM
VAYK Reached Agreement on Terms to Acquire $1 Million Company for Disruptive Airbnb Strategy • VAYK • Dec 2, 2024 9:00 AM
ILUS Announces Completion of QIND Acquisition by Fusion Fuel (NASDAQ: HTOO) • ILUS • Nov 27, 2024 12:35 PM
Cannabix Technologies Receives Positive Testing Certification for Breath Logix Autonomous Alcohol Breathalyzer • BLO • Nov 26, 2024 8:48 AM
BioQuest, Inc. and BotMakers Expand AI Marketing Services with SpeedLeads XL and MarketScope XL. Bioquest Corp. and BotMakers, Inc. are Partnered to Expand AI Marketing Services with SpeedLead XL and MarketScope XL • BQST • Nov 26, 2024 8:00 AM